Johnson & Johnson (NYSE:JNJ) Stake Increased by Canada Pension Plan Investment Board

Canada Pension Plan Investment Board increased its stake in Johnson & Johnson (NYSE:JNJ) by 33.9% in the second quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 4,696,566 shares of the company’s stock after buying an additional 1,189,900 shares during the quarter. Johnson & Johnson comprises approximately 1.4% of Canada Pension Plan Investment Board’s holdings, making the stock its 15th largest holding. Canada Pension Plan Investment Board owned approximately 0.17% of Johnson & Johnson worth $621,309,000 at the end of the most recent reporting period.

A number of other hedge funds have also added to or reduced their stakes in JNJ. State Street Corp grew its stake in Johnson & Johnson by 4.3% in the first quarter. State Street Corp now owns 160,223,321 shares of the company’s stock valued at $19,955,806,000 after purchasing an additional 6,656,371 shares during the last quarter. Harbour Capital Advisors LLC boosted its holdings in Johnson & Johnson by 13,327.8% in the second quarter. Harbour Capital Advisors LLC now owns 2,501,472 shares of the company’s stock worth $18,909,000 after acquiring an additional 2,482,843 shares in the last quarter. Bank of Nova Scotia boosted its holdings in Johnson & Johnson by 94.5% in the first quarter. Bank of Nova Scotia now owns 1,171,517 shares of the company’s stock worth $145,914,000 after acquiring an additional 569,313 shares in the last quarter. Oppenheimer Asset Management Inc. acquired a new stake in Johnson & Johnson in the first quarter worth about $65,598,000. Finally, CIBC World Markets Inc. boosted its holdings in Johnson & Johnson by 111.8% in the first quarter. CIBC World Markets Inc. now owns 948,655 shares of the company’s stock worth $118,155,000 after acquiring an additional 500,662 shares in the last quarter. Institutional investors and hedge funds own 65.90% of the company’s stock.

JNJ has been the subject of several recent analyst reports. J P Morgan Chase & Co raised their price target on Johnson & Johnson from $140.00 to $148.00 and gave the stock an “overweight” rating in a report on Wednesday, August 16th. Jefferies Group set a $145.00 target price on Johnson & Johnson and gave the stock a “hold” rating in a report on Tuesday, August 15th. Cowen set a $147.00 price target on Johnson & Johnson and gave the company a “buy” rating in a research report on Thursday, August 24th. UBS restated an “underweight” rating on shares of Johnson & Johnson in a research report on Thursday, August 24th. Finally, BMO Capital Markets restated a “buy” rating and issued a $145.00 price objective on shares of Johnson & Johnson in a research report on Friday, September 1st. Four analysts have rated the stock with a sell rating, seven have issued a hold rating and eleven have given a buy rating to the stock. The stock has a consensus rating of “Hold” and a consensus price target of $144.59.

Johnson & Johnson (NYSE:JNJ) traded down $1.05 on Thursday, reaching $140.01. The company had a trading volume of 4,713,146 shares, compared to its average volume of 5,871,537. Johnson & Johnson has a 1 year low of $109.93 and a 1 year high of $144.35. The company has a current ratio of 1.32, a quick ratio of 1.02 and a debt-to-equity ratio of 0.36. The firm has a market cap of $375,226.25, a price-to-earnings ratio of 19.56, a price-to-earnings-growth ratio of 2.84 and a beta of 0.80.

Johnson & Johnson (NYSE:JNJ) last issued its quarterly earnings results on Tuesday, October 17th. The company reported $1.90 earnings per share for the quarter, topping the Thomson Reuters’ consensus estimate of $1.80 by $0.10. Johnson & Johnson had a return on equity of 27.38% and a net margin of 21.28%. The company had revenue of $19.65 billion for the quarter, compared to the consensus estimate of $19.29 billion. During the same quarter in the prior year, the business earned $1.68 EPS. Johnson & Johnson’s revenue was up 10.3% on a year-over-year basis. research analysts anticipate that Johnson & Johnson will post 7.28 earnings per share for the current year.

The business also recently declared a quarterly dividend, which will be paid on Tuesday, December 12th. Shareholders of record on Tuesday, November 28th will be issued a dividend of $0.84 per share. The ex-dividend date is Monday, November 27th. This represents a $3.36 annualized dividend and a yield of 2.40%. Johnson & Johnson’s dividend payout ratio (DPR) is 58.33%.

WARNING: “Johnson & Johnson (NYSE:JNJ) Stake Increased by Canada Pension Plan Investment Board” was originally reported by Dispatch Tribunal and is owned by of Dispatch Tribunal. If you are viewing this news story on another website, it was stolen and republished in violation of US & international copyright & trademark laws. The correct version of this news story can be accessed at https://www.dispatchtribunal.com/2017/12/07/johnson-johnson-jnj-holdings-raised-by-canada-pension-plan-investment-board.html.

Johnson & Johnson Profile

Johnson & Johnson is a holding company, which is engaged in the research and development, manufacture and sale of a range of products in the healthcare field. It operates through three segments: Consumer, Pharmaceutical and Medical Devices. Its primary focus is products related to human health and well-being.

Institutional Ownership by Quarter for Johnson & Johnson (NYSE:JNJ)

Receive News & Ratings for Johnson & Johnson Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Johnson & Johnson and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply